Lundbeck / Novartis / Apotex / Lannett / Acorda / Celgene / Roxane Laboratories / Actelion / New York Times / Gilead Sciences / Accord Healthcare / /
Continent
America / /
Country
United States / /
Currency
USD / /
Event
Legal Issues / M&A / /
Facility
United States District Court / /
IndustryTerm
retail pharmacies / industry trade / generics manufacturer / pharmaceutical / brand-name pharmaceutical / drug maker / landmark law expanding access / /
MedicalCondition
movement disorder / Huntington’s disease / multiple sclerosis / leukemia / cancer / leprosy / lung disorder / /
Organization
Food and Drug Administration / United States District Court / Federal Trade Commission / United States District Court for the Southern District of Florida / Congress / /
Person
Steve Giuli / KATIE THOMAS / Markus Meier / Henry A. Waxman / Sally Benjamin Young / Julie Masow / /
Position
spokesman / head of government / speaker / industry lobbyist / spokeswoman / spokeswoman for the industry trade group / Representative / attorney general / /
Drug Makers Use Safety Rule to Block Generics By KATIE THOMAS New York Times, APRIL 15, 2013 For decades, pharmaceutical companies have deployed an array of tactics aimed at preventing low-cost copies of their drugs from